Point72 Middle East FZE’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,395
Closed -$22.3K 1015
2023
Q4
$22.3K Buy
+1,395
New +$22.3K ﹤0.01% 808